Sarcopenia accompanied by systemic inflammation can predict clinical outcomes in patients with head and neck cancer undergoing curative therapy

ObjectivesEvaluation of sarcopenia accompanied by systemic inflammation status is a more beneficial prognostic marker than sarcopenia alone in various cancers. However, few studies have focused on this combination in patients with head and neck squamous cell cancer (HNSCC). In this study, we investi...

Full description

Bibliographic Details
Main Authors: Ken Kasahara, Takeyuki Kono, Yoichiro Sato, Masafumi Ueno, Hirotaka So, Yoshimitsu Fuse, Seiichi Shinden, Hiroyuki Ozawa
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1378762/full